Table 2 Clinical and disease characteristics
From: Actigraphy as a diagnostic aid for REM sleep behavior disorder in Parkinson’s disease
RBD+ | RBD- | p | |
|---|---|---|---|
N | 23 | 22 | |
Men (%) | 17 (73.9) | 13 (59.1) | .292 |
Age (yr) | 64.3 ± 9.4 | 58.1 ± 8.8 | .028 |
Disease characteristics | |||
Disease duration (yr) | 9.5 ± 6.4 | 4.3 ± 2.8 | .024 |
LED (mg/day) | 1089.4 ± 582.9 | 697.7 ± 563.1 | .027 |
LED night (mg/day) | 117.2 ± 51.8 | 140.6 ± 40.9 | .298 |
Hoehn & Yahr (%) | .025 | ||
1 | - | 2 (9.1) | |
1.5 | - | 4 (18.2) | |
2 | 16 (69.6) | 13 (59.1) | |
2.5 | 4 (17.4) | - | |
3 | 3 (13.0) | 3 (13.6) | |
Use of anti-depressants | |||
SSRI (%) | 4 (17.4) | 4 (18.2) | .945 |
TCA (%) | - | 2 (9.1) | .139 |
Other (%) | 3 (13.0) | - | .080 |